These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31780938)

  • 1. Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases.
    Morgado-Pascual JL; Rayego-Mateos S; Tejedor L; Suarez-Alvarez B; Ruiz-Ortega M
    Front Pharmacol; 2019; 10():1315. PubMed ID: 31780938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity.
    Sartor GC; Powell SK; Brothers SP; Wahlestedt C
    J Neurosci; 2015 Nov; 35(45):15062-72. PubMed ID: 26558777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
    Taniguchi Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.
    Borck PC; Guo LW; Plutzky J
    Circ Res; 2020 Apr; 126(9):1190-1208. PubMed ID: 32324495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles.
    Ali HA; Li Y; Bilal AHM; Qin T; Yuan Z; Zhao W
    Front Pharmacol; 2022; 13():818891. PubMed ID: 35401196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the epigenetic reader "BET" as a therapeutic strategy for cancer.
    Wahi A; Manchanda N; Jain P; Jadhav HR
    Bioorg Chem; 2023 Nov; 140():106833. PubMed ID: 37683545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Functions of BET Proteins in Gene Transcription of Biology and Diseases.
    Cheung KL; Kim C; Zhou MM
    Front Mol Biosci; 2021; 8():728777. PubMed ID: 34540900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury.
    Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK
    Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.
    To KKW; Xing E; Larue RC; Li PK
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BET Bromodomain as a Target of Epigenetic Therapy.
    Noguchi-Yachide T
    Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT.
    Miller TC; Simon B; Rybin V; Grötsch H; Curtet S; Khochbin S; Carlomagno T; Müller CW
    Nat Commun; 2016 Dec; 7():13855. PubMed ID: 27991587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-Molecule Targeting of BET Proteins in Cancer.
    French CA
    Adv Cancer Res; 2016; 131():21-58. PubMed ID: 27451123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery.
    Fu LL; Tian M; Li X; Li JJ; Huang J; Ouyang L; Zhang Y; Liu B
    Oncotarget; 2015 Mar; 6(8):5501-16. PubMed ID: 25849938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases.
    Ji Y; Chen W; Wang X
    J Pharmacol Exp Ther; 2024 May; 389(3):277-288. PubMed ID: 38565308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell.
    Deeney JT; Belkina AC; Shirihai OS; Corkey BE; Denis GV
    PLoS One; 2016; 11(3):e0151329. PubMed ID: 27008626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.
    Tang P; Zhang J; Liu J; Chiang CM; Ouyang L
    J Med Chem; 2021 Mar; 64(5):2419-2435. PubMed ID: 33616410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers.
    Sun HY; Du ST; Li YY; Deng GT; Zeng FR
    World J Gastrointest Oncol; 2022 Jan; 14(1):75-89. PubMed ID: 35116104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of estrogen receptor function to BET bromodomain inhibition is mediated by transcriptional coactivator cooperativity.
    Zhang S; Roeder RG
    Nat Struct Mol Biol; 2024 Sep; ():. PubMed ID: 39251822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain.
    Law RP; Atkinson SJ; Bamborough P; Chung CW; Demont EH; Gordon LJ; Lindon M; Prinjha RK; Watson AJB; Hirst DJ
    J Med Chem; 2018 May; 61(10):4317-4334. PubMed ID: 29656650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromodomains: Structure, function and pharmacology of inhibition.
    Ferri E; Petosa C; McKenna CE
    Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.